Balance Sheet - ARS Pharmaceuticals, Inc. (SPRY)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | |
|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 244.99 | 314.02 | 228.36 | 274.38 | 60.06 | 24.52 | 9.98 | 20.16 |
| Accounts receivable, net | 25.35 | 9.16 | 0.80 | 1.01 | 0.00 | 0.38 | ||
| Inventories | 8.37 | 5.21 | 0.00 | -1.01 | -6.78 | -2.61 | ||
| Other current assets | 6.19 | 5.90 | 2.41 | 3.32 | 0.67 | 1.48 | 0.55 | 0.62 |
| Total current assets | 284.90 | 334.30 | 231.56 | 277.70 | 60.73 | 26.38 | 10.53 | 20.78 |
| Total non-current assets | 42.76 | 16.86 | 1.63 | 3.74 | 0.72 | 0.03 | 5.12 | 6.77 |
| Total assets | 327.65 | 351.15 | 233.19 | 281.44 | 61.45 | 26.41 | 15.65 | 27.55 |
| Total current liabilities | 39.15 | 23.44 | 2.39 | 5.44 | 8.19 | 8.21 | 17.93 | 5.14 |
| Total non-current liabilities | 174.25 | 70.92 | 0.04 | 3.11 | 84.53 | 32.25 | 3.32 | 4.21 |
| Total liabilities | 213.39 | 94.36 | 2.43 | 8.55 | 92.72 | 40.46 | 21.25 | 9.35 |
| Total stockholders' equity | 114.26 | 256.80 | 230.76 | 272.89 | -31.27 | -14.05 | -5.60 | 18.20 |
| Common shares outstanding | 99 | 102 | 95 | 40 | 29 | 35 | 33 | 33 |
Show Quarterly Balance Sheet
Balance Sheet - ARS Pharmaceuticals, Inc. (SPRY)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Jun-20 | Mar-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 200.97 | 244.99 | 288.21 | 240.13 | 275.73 | 314.02 | 204.62 | 218.74 | 223.63 | 228.36 | 241.90 | 252.21 | 264.55 | 274.38 | 100.72 | 83.88 | 253.85 | 60.06 | 300.66 | 359.69 | 374.21 | 386.57 | 0.00 | 0.00 | 9.98 |
| Accounts receivable, net | 28.66 | 25.35 | 36.45 | 26.08 | 10.27 | 9.16 | 1.24 | 0.54 | 0.62 | 0.80 | 0.81 | 0.96 | 0.52 | 1.01 | 0.40 | 0.04 | 0.04 | 0.00 | 0.00 | ||||||
| Inventories | 8.82 | 8.37 | 7.78 | 8.74 | 7.27 | 5.21 | 0.72 | 0.00 | -0.81 | -0.96 | -0.52 | -1.01 | |||||||||||||
| Other current assets | 6.79 | 6.19 | 6.42 | 6.49 | 10.59 | 5.90 | 2.21 | 1.45 | 1.99 | 2.41 | 1.75 | 2.83 | 2.28 | 3.32 | 1.77 | 0.76 | 7.49 | 0.67 | 4.70 | 3.34 | 4.14 | 4.09 | 0.55 | ||
| Total current assets | 245.24 | 284.90 | 338.86 | 281.44 | 303.86 | 334.30 | 208.79 | 220.74 | 226.24 | 231.56 | 244.47 | 255.03 | 267.35 | 277.70 | 39.10 | 45.39 | 261.33 | 60.73 | 305.36 | 363.03 | 378.35 | 390.66 | 10.53 | ||
| Total non-current assets | 42.34 | 42.76 | 33.94 | 32.04 | 23.46 | 16.86 | 8.81 | 1.23 | 1.34 | 1.63 | 4.09 | 3.72 | 3.84 | 3.74 | 0.64 | 0.66 | 51.14 | 0.72 | 47.21 | 3.95 | 3.85 | 4.15 | 5.12 | ||
| Total assets | 287.57 | 327.65 | 372.80 | 313.47 | 327.32 | 351.15 | 217.60 | 221.97 | 227.58 | 233.19 | 248.56 | 258.75 | 271.19 | 281.44 | 39.73 | 46.05 | 312.47 | 61.45 | 352.56 | 366.98 | 382.20 | 394.80 | 15.65 | ||
| Total current liabilities | 49.61 | 39.15 | 50.88 | 45.60 | 27.62 | 23.44 | 16.62 | 6.73 | 3.72 | 2.39 | 11.18 | 10.05 | 9.84 | 5.44 | 8.33 | 7.46 | 14.81 | 8.19 | 15.35 | 15.55 | 11.60 | 9.60 | 17.93 | ||
| Total non-current liabilities | 176.65 | 174.25 | 174.27 | 75.55 | 70.72 | 70.92 | 0.00 | 0.00 | 0.00 | 0.04 | 0.09 | 0.15 | 0.20 | 3.11 | 5.52 | 82.62 | 4.43 | 84.53 | 5.08 | 1.78 | 2.06 | 2.33 | 3.32 | ||
| Total liabilities | 226.26 | 213.39 | 225.15 | 121.15 | 98.34 | 94.36 | 16.62 | 6.73 | 3.72 | 2.43 | 11.27 | 10.20 | 10.04 | 8.55 | 13.85 | 90.08 | 19.24 | 92.72 | 20.43 | 17.33 | 13.65 | 11.93 | 21.25 | ||
| Total stockholders' equity | 61.31 | 114.26 | 147.66 | 192.32 | 228.97 | 256.80 | 200.98 | 215.24 | 223.87 | 230.76 | 237.28 | 248.55 | 261.15 | 272.89 | 25.88 | -44.03 | 293.23 | -31.27 | 332.13 | 349.65 | 368.55 | 382.88 | -5.60 | ||
| Common shares outstanding | 99 | 99 | 99 | 98 | 98 | 98 | 97 | 97 | 96 | 96 | 96 | 95 | 94 | 94 | 94 | 94 | 94 | 35 | 35 | 35 | 35 | 35 | 35 | 33 | 33 |